Thanks for reading. If you would like to get in touch with policy/strategy to discuss any of our Case Studies, Insights or learn more about the Services we offer, please contact us.
Reading No
As negotiations over the WHO Pandemic Agreement stall, a growing number of African governments are rejecting bilateral health deals they see as compromising sovereignty and equity. The deeper question is no longer whether African states can refuse, but what exactly they are refusing, and on whose behalf.
Study Design as the Determinant of Bioequivalence Outcomes: Implications for Regulatory Science and Access to Medicines in Africa
Explore the bioequivalence framework and its critical role in generic medicine approval and study design for successful outcomes.
